证券代码：603599 股票简称：广信股份 编号：2025-005 安徽广信农化股份有限公司 关于 2024 年度募集资金存放与使用情况的专项报告的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、募集资金基本情况 经中国证券监督管理委员会《关于核准安徽广信农化股份有限公司非公开发行股票 的批复》（证监许可[2017]1429 号文）的核准，本公司向特定投资者嘉实基金管理有限 公司、华融证券股份有限公司、富国基金管理有限公司、博时基金管理有限公司、华商 基金管理有限公司、安徽高新毅达皖江产业发展创业投资基金（有限合伙）、鹏华基金 管理有限公司、财通基金管理有限公司、北信瑞丰基金管理有限公司发行人民币普通股 （A股）88,199,135 股，每股发行价为16.27 元，应募集资金总额为人民币1,434,999,926.45 元，根据有关规定扣除发行费用人民币 36,099,000.00 元后，实际募集资金金额为人民币 1,398,900,926.45 元，上述资金到账情况业经华普天健会计师事务所（特殊普通合伙）会 ...

国元证券股份有限公司 关于安徽广信农化股份有限公司 2024 年度 募集资金存放与实际使用情况的专项核查报告 国元证券股份有限公司（以下简称"国元证券"或"保荐机构"）作为安徽 广信农化股份有限公司（以下简称"广信股份"或"公司"）非公开发行股票并 上市持续督导工作的保荐机构，根据《证券发行上市保荐业务管理办法》、《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》、《上海证券 交易所股票上市规则》、《上海证券交易所上市公司自律监管指引第 11 号——持 续督导》等相关法规和规范性文件的要求，对广信股份 2024 年度募集资金存放 与使用情况进行了专项核查，具体核查情况说明如下： 一、募集资金情况 经中国证券监督管理委员会《关于核准安徽广信农化股份有限公司非公开发 行股票的批复》（证监许可[2017]1429 号文）的核准，广信股份向特定投资者嘉 实基金管理有限公司、华融证券股份有限公司、富国基金管理有限公司、博时基 金管理有限公司、华商基金管理有限公司、安徽高新毅达皖江产业发展创业投资 基金（有限合伙）、鹏华基金管理有限公司、财通基金管理有限公司、北信瑞丰 基金管理有限公司非公开发行人民 ...

证券代码：603599 证券简称：广信股份 安徽广信农化股份有限公司 2024 年度审计委员会履职情况报告 2024 年，董事会审计委员会严格按照中国证监会、上海证券交易所的相关 规定和公司章程、《公司董事会审计委员会实施细则》的相关规定，切实履行职 责，认真、规范地完成了各项工作。现将 2024 年度履职情况报告如下： 一、审计委员会基本情况 2024 年度，审计委员会共召开了 4 次会议，具体情况如下： 2024 年 4 月 13 日，召开了审计委员会 2024 年第一次会议：1、会计 师就 2023 年报审计中确认的关键审计事项进行了沟通；2、双方就容诚会计师 事务所（特殊普通合伙）出具的 2023 年审计报告正文最新稿进行讨论； 3、 就公司与辽宁世星药化解除协议事项进行有关询问与沟通。 2024 年 4 月 14 日，召开了审计委员会 2024 年第二次会议，审议通过 了：1、《2023 年年度报告全文及摘要》；2、《审计委员会年度履职情况》；3、 《2023 年度利润分配预案》；4、《2023 年度内部控制评价报告》 5、《续聘年度 审计机构议案》；6、《关于 2023 年度募集资金存放与实际使用 ...

一、 召开会议的基本情况 证券代码：603599 证券简称：广信股份 公告编号：2025-009 安徽广信农化股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (一)股东大会类型和届次 2024年年度股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 5 月 23 日 14 点 00 分 召开地点：广信股份总部大楼 股东大会召开日期：2025年5月23日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 5 月 23 日 至2025 年 5 月 23 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30- ...

安徽广信农化股份有限公司 第六届监事会第三次会议决议公告 证券代码：603599 证券简称：广信股份 编号：2025-003 安徽广信农化股份有限公司（以下简称"公司"）于 2025 年 4 月 25 日，在 公司会议室召开第六届监事会第三次会议。会议应到监事 3 人，实到监事 3 人。 会议由监事会主席程伟家主持，会议的召集、召开符合《公司法》及《公司章程》 的有关规定。与会监事审议并通过如下决议： 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏并 对其内容的真实性、准确性和完整性承担个别及连带责任。 一、审议通过《2024 年度监事会工作报告》 具体内容详见上海证券交易所网站(www.sse.com.cn)相关公告 本议案尚需提交 2024 年年度股东大会审议。 表决结果：3 票赞成，0 票反对，0 票弃权。 二、审议通过《2024 年年度报告》及其摘要，并发表如下审核意见： 1、《2024 年年度报告》的编制和审议程序符合法律、法规、《公司章程》 和公司内部管理制度的各项规定。 2、《2024 年年度报告》的内容和格式符合中国证监会和上海证券交易所的 各项规定，所包含的信 ...

证券代码：603599 证券名称：广信股份 公告编号：2025-002 安徽广信农化股份有限公司 第六届董事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 安徽广信农化股份有限公司（以下简称"公司"）第六届董事会第四次会议 于 2025 年 4 月 25 日召开。本次会议应参会董事 9 人，实际参会董事 9 人，会议 由公司董事长黄金祥先生主持，符合《公司法》和《公司章程》等的相关规定， 会议合法有效。 二、董事会会议审议情况 （一）审议通过《公司 2024 年度董事会工作报告》 该报告全文详见上海证券交易所网站(www.sse.com.cn)。 本报告需提请公司 2024 年年度股东大会审议。 表决结果：同意 9 票，反对 0 票，弃权 0 票 （二）审议通过《公司 2024 年年度报告》及其摘要 该报告全文详见上海证券交易所网站(www.sse.com.cn)。 董事会审计委员会对财务会计报告及定期报告中的财务信息发表了审 核意见。 本报告需提请公司 2024 年年度股东 ...

证券代码：603599 证券简称：广信股份 公告编号：2025-004 安徽广信农化股份有限公司 关于 2024 年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： A 股每 10 股派发现金红利 2.7 元 本次利润分配以实施权益分派股权登记日登记的总股本为基数，具体 日期将在权益分派实施公告中明确。 一、利润分配方案内容 经容诚会计师事务所（特殊普通合伙）审计，安徽广信农化股份有限公司（ 以下简称"公司"）本报告期内实现归属于上市公司股东的净利润为 778,737,899.57元，期末可供分配利润为6,448,628,239.68元。经董事会决议， 公司2024年年度拟以实施权益分派股权登记日登记的总股本为基数分配利润。本 次利润分配方案如下： 公司拟向全体股东每 10 股派发现金红利 2.7 元（含税）。截至 2024 年 12 月 31 日 ， 公 司 总 股 本 910,269,345 股 ， 以 此 计 算 合 计 拟 派 发 现 金 红利 245,772,723.15 元 ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 981,790,598.51, a decrease of 19.22% compared to CNY 1,215,462,107.45 in the same period last year[4] - Net profit attributable to shareholders was CNY 160,987,170.77, down 28.50% from CNY 225,164,722.64 year-on-year[4] - Basic earnings per share were CNY 0.18, reflecting a decline of 28.00% from CNY 0.25 in the same period last year[4] - The decline in revenue and profit was primarily due to a decrease in sales prices and volumes of major products[7] - Operating profit for Q1 2025 was CNY 180,915,670.76, down from CNY 246,847,751.75 in the same period last year, reflecting a decline of approximately 27%[20] - The total comprehensive income for Q1 2025 was CNY 160,987,170.77, down from CNY 220,549,007.88 in Q1 2024, indicating a decline of about 27%[21] Cash Flow and Assets - The net cash flow from operating activities decreased by 52.03%, amounting to CNY 103,495,318.82 compared to CNY 215,745,154.49 in the previous year[4] - Cash flow from operating activities for Q1 2025 was CNY 103,495,318.82, a decrease of 52% compared to CNY 215,745,154.49 in Q1 2024[25] - Total cash inflow from investment activities in Q1 2025 was CNY 2,756,794,667.59, down from CNY 3,549,971,586.99 in Q1 2024[24] - Cash flow from financing activities in Q1 2025 resulted in a net outflow of CNY 195,622,442.28, compared to a net outflow of CNY 421,993,513.53 in Q1 2024[26] - The total cash and cash equivalents at the end of Q1 2025 was CNY 1,116,536,434.06, down from CNY 6,900,931,002.74 at the end of Q1 2024[26] Assets and Liabilities - Total assets at the end of the reporting period were CNY 14,564,743,581.40, a slight decrease of 0.66% from CNY 14,661,310,074.44 at the end of the previous year[5] - Current assets totaled RMB 8,600,538,001.38 as of March 31, 2025, down from RMB 9,851,459,919.72 at the end of 2024[14] - Non-current assets increased to RMB 5,964,205,580.02 as of March 31, 2025, compared to RMB 4,809,850,154.72 at the end of 2024[15] - Total liabilities decreased to RMB 4,694,777,398.49 as of March 31, 2025, from RMB 4,956,252,497.70 at the end of 2024[16] - Shareholders' equity increased to RMB 9,869,966,182.91 as of March 31, 2025, compared to RMB 9,705,057,576.74 at the end of 2024[16] Expenses - Total operating costs for Q1 2025 were RMB 826,145,617.82, down 14.2% from RMB 963,512,691.46 in Q1 2024[19] - Operating costs included RMB 682,560,944.35 in cost of goods sold for Q1 2025, a decrease of 17.4% from RMB 826,715,159.76 in Q1 2024[19] - Research and development expenses for Q1 2025 were CNY 51,382,661.16, a decrease of 30% from CNY 73,909,641.06 in Q1 2024[20] - Sales expenses increased to CNY 11,905,240.76 in Q1 2025, compared to CNY 10,706,706.58 in Q1 2024, reflecting an increase of approximately 11%[20] Shareholder Information - The total number of common shareholders at the end of the reporting period was 19,184[9] - The equity attributable to shareholders increased by 1.70% to CNY 9,869,966,182.91 from CNY 9,705,057,576.74 at the end of the previous year[5] Gains and Losses - Non-recurring gains and losses totaled CNY 35,379,372.01, with a tax impact of CNY 6,243,418.59[6] - The company reported a significant increase in investment income, reaching CNY 34,053,467.93 in Q1 2025, compared to a loss of CNY 62,917,785.69 in Q1 2024[20] - The company reported a significant increase in accounts receivable, which rose to RMB 134,960,422.45 in Q1 2025 from RMB 93,972,329.01 in Q1 2024[14]

Financial Performance - The company's total revenue for 2024 was approximately ¥4.64 billion, a decrease of 20.88% compared to ¥5.87 billion in 2023[22]. - Net profit attributable to shareholders for 2024 was approximately ¥778.74 million, down 45.88% from ¥1.44 billion in 2023[22]. - The net cash flow from operating activities for 2024 was approximately ¥535.30 million, a decline of 26.92% compared to ¥732.49 million in 2023[23]. - The total assets at the end of 2024 were approximately ¥14.66 billion, a decrease of 5.51% from ¥15.52 billion at the end of 2023[23]. - The net assets attributable to shareholders increased by 2.33% to approximately ¥9.71 billion at the end of 2024, compared to ¥9.48 billion at the end of 2023[23]. - The company reported a decrease in net profit after deducting non-recurring gains and losses, which was approximately ¥702.85 million, down 45.92% from ¥1.30 billion in 2023[22]. - Basic earnings per share fell by 45.57% to 0.86 RMB per share[26]. - The weighted average return on equity decreased by 7.66 percentage points to 8.08%[24]. - The gross profit margin for the pesticide and pesticide intermediates segment was 30.74%, reflecting a decrease of 6.72 percentage points compared to the previous year[55]. - The company reported a significant decline in financing cash flow, which decreased by 79.18% to approximately ¥180 million from ¥864 million year-on-year[50]. Dividend Policy - The company plans to distribute a cash dividend of ¥2.7 per 10 shares, totaling approximately ¥245.77 million, based on a total share capital of 910,269,345 shares[6]. - The company maintains a stable profit distribution policy, prioritizing cash dividends, with a minimum cash distribution of 30% of the average distributable profit over three consecutive years when conditions are met[144]. - In the event of significant capital expenditures, the minimum cash dividend ratio is set at 40% for mature companies and 20% for growth-stage companies[144]. - The independent directors are responsible for ensuring that the cash dividend policy is executed properly and that minority shareholders' rights are protected[148]. - Over the last three fiscal years, the cumulative cash dividend amount (including tax) reached 1,637,266,335.85 RMB, with a cash dividend ratio of 107.13% based on the average annual net profit of 1,528,249,614.01 RMB[152]. Market Conditions and Challenges - The company faced challenges such as supply-demand imbalance and price fluctuations in the global pesticide market[34]. - The decline in product prices and sales volume significantly impacted profitability[25]. - During the reporting period, pesticide prices remained in a downward trend due to high shipping costs, changes in customer ordering strategies, and increased competition from low-cost Indian pesticides[39]. - The agricultural chemical market is expected to stabilize due to rigid demand for food and the expansion of planting areas in South America, despite current price adjustments[38]. - The company is navigating a period of industry adjustment and increased market competition[34]. Research and Development - The company has invested in a 4,000 square meter R&D center, enhancing its research capabilities and fostering partnerships with academic institutions[45]. - The company has developed several core technologies, including DAP/HAP impurity control and thiocyanate reaction technology, positioning itself as a leader in production technology within the industry[44]. - The company has established a technical center since 2003, focusing on research and development, and has completed the construction of a new R&D building in 2022 to enhance production-related research[85]. - The company has a performance evaluation system for senior management, which includes comprehensive assessments based on annual performance, management capabilities, and employee evaluations[153]. Governance and Compliance - The company has established a sound internal control system and governance structure, ensuring compliance with relevant laws and regulations[116]. - The board of directors has effectively made decisions on significant matters such as capital increases and director appointments, maintaining shareholder rights[116]. - The company has not faced any penalties from securities regulatory agencies in the past three years, indicating compliance with regulations[129]. - The company has not disclosed any major differences in governance compared to regulatory requirements, indicating compliance[117]. - The company has established a policy to communicate with shareholders, especially minority shareholders, to gather their opinions before finalizing cash dividend proposals[145]. Environmental Responsibility - The company invested 97.1625 million yuan in environmental protection during the reporting period[158]. - The company has established a dedicated pollution control facility that ensures stable and compliant emissions[161]. - The company has implemented environmental impact assessments and related work for construction projects in compliance with regulations[163]. - The company is actively promoting green development, focusing on waste reduction and improving air quality management[168]. - The company has established an energy management office to enhance energy utilization and carbon emission management[169]. Production and Supply Chain - The company has established a comprehensive production system for pesticide raw materials and intermediates, making it one of the few specialized manufacturers in the industry[40]. - The company has a total production capacity of 320,000 tons/year for phosgene, making it the largest among private pesticide enterprises in China[77]. - The company adopts an "order-driven + safety stock" business model, with sales being the central focus of its operations[78]. - The company has implemented strict quality management for procurement, requiring new suppliers to pass three verification procedures before being included in the qualified supplier list[83]. - The company has a dynamic management system for supplier assessment, focusing on qualifications, supply capacity, pricing, and quality assurance[84]. Strategic Initiatives - The company aims to enhance its supply chain autonomy and product offerings by leveraging its phosgene resources and expanding its product structure[42]. - The company intends to pursue mergers and acquisitions to enhance its product line and market share, focusing on strategic timing and complementary advantages[108]. - The company is actively expanding its market presence and product lines, focusing on innovation and technology advancement to maintain competitive advantages[85]. - The company plans to expand its market share by strengthening its brand and accelerating the development of new sales channels, targeting international markets such as the USA, Brazil, and Argentina[102]. Workforce and Management - The company employed a total of 2,015 staff, with 871 in the parent company and 1,143 in major subsidiaries[138]. - The workforce includes 1,680 production personnel, 33 sales personnel, 22 technical staff, 21 financial staff, and 259 administrative staff[138]. - The company’s management structure includes experienced professionals with backgrounds in finance, engineering, and management, enhancing operational efficiency[124]. - The remuneration for senior management is linked to annual performance evaluations, ensuring alignment with the company's operational goals[127].

证券代码：603599 证券简称：广信股份 公告编号：2025-001 会议召开时间：2025 年 04 月 29 日 （星期二） 15:00-16:00 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 安徽广信农化股份有限公司（以下简称"公司"）已于 2025 年 4 月 28 日发布公司 2024 年度报告，为便于广大投资者更全面深入 地了解公司 2024 年度经营成果、财务状况，公司计划于 2025 年 04 月 29 日 （星期二） 15:00-16:00 举行 2024 年度暨 2025 年第一季 度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 安徽广信农化股份有限公司 关于召开 2024 年度暨 2025 年第一季度业绩说明会 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： （三） 会议召开方式：上证路演中心网络互动 三、 参加人员 董事长、总经理：黄金祥 财务总监：何王珍 本次投资者说明会以网络互动形式召开，公司 ...